AzTrials
AzTrials

Maxillary Sinus LiftNCT03177876

Sinus Lift With Hydroxyapatite Nano Particles Versus Tenting Technique

A study testing sinus lift implant placement Hydroxyapatite Nano particles and sinus lift implant placement tenting in people with Maxillary Sinus Lift, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

twenty recruited patients indicated for sinus augmentation and immediate implant placement will be divided into two groups (10 in each of the two groups), to compare bone formation and implant stability after shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles [Nanostreams] or… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Maxillary Sinus Lift
What is being tested?
sinus lift implant placement Hydroxyapatite Nano particles and sinus lift implant placement tenting
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
Jul 2016to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with atrophic maxilla and pneumatization of the maxillary sinus with residual bone height at least 5mm of residual ridge as per MISCH criteria
  • Both sexes

Who cannot join

  • Sinus pathology
  • Heavy smokers more than 20 cigarettes per day
  • Patients with systemic disease that may affect normal healing

About this study

Official title: Schneiderian Membrane Elevation and Augmentation With Hydroxyapatite Nano Particles [ Nano Streams ] Versus Graft Less Tenting Technique With Simultaneous Implant Placement: Randomized Clinical Trial

twenty recruited patients indicated for sinus augmentation and immediate implant placement will be divided into two groups (10 in each of the two groups), to compare bone formation and implant stability after shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles [Nanostreams] or augmentation with graft less tenting technique with simultaneous implant placement.

Being tested
sinus lift implant placement Hydroxyapatite Nano particles, sinus lift implant placement tenting
Keywords
tenting Hydroxyapetite nano particles implant immediate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sinus lift implant placement Hydroxyapatite Nano particlesProcedure or surgery

    shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles with simultaneous implant placement

  • sinus lift implant placement tentingProcedure or surgery

    shneiderian membrane elevation and augmentation with graft less tenting technique with simultaneous implant placement

Study groups in NCT03177876
Study groupRoleWhat they receive
sinus lift implant placement Hydroxyapatite Nano particlesExperimentalshneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles [Nanostreams] with simultaneous implant placement
Receives: Procedure: sinus lift implant placement Hydroxyapatite Nano particles
sinus lift implant placement tentingActive comparatorshneiderian membrane elevation and augmentation with graft less tenting technique with simultaneous implant placement
Receives: Procedure: sinus lift implant placement tenting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. patient satisfaction

    evaluation of post operative complications in terms of pain and edema using patient pain chart

    Measured: 7 days post operative

Secondary outcomes (2)
  1. implant stability

    measurement of the implant stability using osstell device

    Measured: will be measured intra-operative after implant insertion and will be measured one more time 6 months after the first operation at the time of implant exposure

  2. height of bone gain or loss around the implant

    two cone beam CT will be taken for the patients, one immediate post operative and the other 6 months post-operative then the amount of bone gained or loss will be assessed by superimposing the same section in the two cone beam CT

    Measured: 6 months post operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2017
  2. Study startJul 2016
  3. Primary completionJun 2017 (estimated)
  4. Study completionJul 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03177876
Sponsor's protocol ID
cebc.cairo university
Status last verified
Jun 2017
First submitted
19 May 2017
Last updated
6 Jun 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing sinus lift implant placement Hydroxyapatite Nano particles and sinus lift implant placement tenting in people with Maxillary Sinus Lift, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

patient satisfaction (time frame: 7 days post operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in